[ADRENOCORTICAL CARCINOMA].
Kranjčević K.
Acta Med Croatica. 2016 Dec;70(4-5):315-8.
Mild autonomous cortisol secretion: pathophysiology, comorbidities and management approaches.
Prete A, Bancos I.
Nat Rev Endocrinol. 2024 Aug;20(8):460-473. doi: 10.1038/s41574-024-00984-y. Epub 2024 Apr 22.
Adrenal Adenoma.
Mahmood E, Loughner CL, Anastasopoulou C.
2023 Aug 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Rare benign adrenal lesions.
Dogra P, Sundin A, Juhlin CC, Calissendorff J, Falhammar H, Bancos I.
Eur J Endocrinol. 2023 Apr 5;188(4):407-420. doi: 10.1093/ejendo/lvad036.
Non-functioning adrenocortical carcinoma.
Lenh BV, Duc NM, Tra My TT, Minh TN, Bang LV, Linh LT, Giang BV, Thong PM.
Radiol Case Rep. 2021 Apr 3;16(6):1329-1334. doi: 10.1016/j.radcr.2021.03.006. eCollection 2021 Jun.
Primary adrenocortical carcinoma: a case report.
Neupane D, Khadka S, Upadhyaya P, Sah SP, Dulal S, Shah SK, Shah UK.
Ann Med Surg (Lond). 2023 Mar 27;85(5):1834-1838. doi: 10.1097/MS9.0000000000000097. eCollection 2023 May.
Management of Adrenal Masses.
Bhat HS, Tiyadath BN.
Indian J Surg Oncol. 2017 Mar;8(1):67-73. doi: 10.1007/s13193-016-0597-y. Epub 2016 Dec 17.
Screening in adrenal tumors.
Corssmit EPM, Dekkers OM.
Curr Opin Oncol. 2019 May;31(3):243-246. doi: 10.1097/CCO.0000000000000528.
Genetics and epigenetics of adrenocortical tumors.
Lerario AM, Moraitis A, Hammer GD.
Mol Cell Endocrinol. 2014 Apr 5;386(1-2):67-84. doi: 10.1016/j.mce.2013.10.028. Epub 2013 Nov 9.
Adrenocortical carcinoma.
Schulick RD, Brennan MF.
World J Urol. 1999 Feb;17(1):26-34. doi: 10.1007/s003450050101.
